CIK 0001477449
- Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043705970
- Phone
- +1 203-635-2002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-02 | Verstraete Stephany Chief Marketing Officer | Option exercise | +3,169 | 8,521 | ||
| 2020-03-02 | Verstraete Stephany Chief Marketing Officer | Shares withheld for taxes | −1,145 | $124.32 | $142K | 7,376 |
| 2020-03-02 | Verstraete Stephany Chief Marketing Officer | Option exercise · Restricted Stock Units | −3,169 | 3,169 | ||
| 2020-03-02 | Verstraete Stephany Chief Marketing Officer | Grant or award · Restricted Stock Units | +5,422 | 5,422 | ||
| 2020-03-02 | Turitz Andrew SVP - Business Development | Option exercise | +2,304 | 6,290 | ||
| 2020-03-02 | Turitz Andrew SVP - Business Development | Shares withheld for taxes | −718 | $124.32 | $89K | 5,572 |
| 2020-03-02 | Turitz Andrew SVP - Business Development | Option exercise · Restricted Stock Units | −2,304 | 2,305 | ||
| 2020-03-02 | Turitz Andrew SVP - Business Development | Grant or award · Restricted Stock Units | +3,615 | 3,615 | ||
| 2020-03-02 | Levy Lewis Chief Medical Officer | Option exercise | +2,881 | 7,261 | ||
| 2020-03-02 | Levy Lewis Chief Medical Officer | Shares withheld for taxes | −899 | $124.32 | $112K | 6,362 |
| 2020-03-02 | Levy Lewis Chief Medical Officer | Option exercise · Restricted Stock Units | −2,881 | 2,881 | ||
| 2020-03-02 | Levy Lewis Chief Medical Officer | Grant or award · Restricted Stock Units | +3,615 | 3,615 | ||
| 2020-03-02 | Cappucci Gabriel R. Senior VP, Controller and CAO | Option exercise | +1,766 | 2,995 | ||
| 2020-03-02 | Cappucci Gabriel R. Senior VP, Controller and CAO | Shares withheld for taxes | −640 | $123.56 | $79K | 2,355 |
| 2020-03-02 | Cappucci Gabriel R. Senior VP, Controller and CAO | Option exercise · Restricted Stock Units | −1,766 | 1,767 | ||
| 2020-03-02 | Cappucci Gabriel R. Senior VP, Controller and CAO | Grant or award · Restricted Stock Units | +3,213 | 3,213 | ||
| 2020-03-02 | Bucaria Michelle Chief Human Resources Officer | Grant or award · Restricted Stock Units | +3,414 | 3,414 | ||
| 2020-03-02 | Sides David William Chief Operating Officer | Grant or award · Restricted Stock Units | +8,033 | 8,033 | ||
| 2020-03-02 | Murthy Mala Chief Financial Officer | Grant or award · Restricted Stock Units | +8,033 | 8,033 | ||
| 2020-03-02 | GOREVIC JASON N Chief Executive Officer | Option exercise | +13,280 | 655,204 |
Page 107 of 113 · 2,249 trades